EUR 3 million for GMP production of new APIs
Bad Homburg v.d. Höhe, August 24, 2022 – The ForTra gGmbH für Forschungstransfer der Else Kröner-Fresenius-Stiftung (ForTra) is supporting the production of new pharmaceutical candidates under GMP conditions for direct use in first-in-human clinical studies involving patients with a total of three million euros.